Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,391 | -288,284 | -229,709 | -115,519 | -73,238 |
| Depreciation Amortization | 1,243 | 6,320 | 3,912 | 1,674 | 871 |
| Accounts receivable | -52,880 | -80,654 | -59,463 | -25,409 | -7,606 |
| Accounts payable and accrued liabilities | 3,584 | 5,279 | 337 | -5,624 | -1,543 |
| Other Working Capital | -105,865 | -8,498 | 93,971 | -69,130 | -37,455 |
| Other Operating Activity | 80,874 | 176,284 | 134,859 | 78,065 | 30,080 |
| Operating Cash Flow | $-167,435 | $-189,553 | $-56,093 | $-135,943 | $-88,891 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 196,040 | 35,787 | 8,597 | 211,736 | 163,878 |
| PPE Investments | -3,849 | -467 | -857 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -3,000 | -3,000 | 0 | N/A |
| Other Investing Activity | 0 | -3,000 | -3,000 | 0 | 0 |
| Investing Cash Flow | $192,191 | $32,320 | $4,740 | $211,736 | $163,878 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 350,000 | 350,000 | N/A | N/A |
| Debt Repayment | N/A | -121,664 | -121,664 | N/A | N/A |
| Common Stock Issued | 2,329 | 38,055 | 28,116 | 10,381 | 8,640 |
| Other Financing Activity | 0 | -10,407 | -9,424 | 0 | 0 |
| Financing Cash Flow | $2,329 | $255,984 | $247,028 | $10,381 | $8,640 |
| Exchange Rate Effect | 1,320 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 203,783 | 105,019 | 105,019 | 105,019 | 105,019 |
| End Cash Position | 232,188 | 203,783 | 300,694 | 191,193 | 188,646 |
| Net Cash Flow | $28,405 | $98,764 | $195,675 | $86,174 | $83,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -167,435 | -189,553 | -56,093 | -135,943 | -88,891 |
| Capital Expenditure | -3,849 | -467 | -857 | 0 | 0 |
| Free Cash Flow | -171,284 | -190,020 | -56,950 | -135,943 | -88,891 |